130 related articles for article (PubMed ID: 15009536)
1. Cyclosporin A prodrugs: design, synthesis and biophysical properties.
Hamel AR; Hubler F; Carrupt A; Wenger RM; Mutter M
J Pept Res; 2004 Feb; 63(2):147-54. PubMed ID: 15009536
[TBL] [Abstract][Full Text] [Related]
2. Water-soluble prodrugs of cyclosporine A with tailored conversion rates.
Hamel AR; Hubler F; Mutter M
J Pept Res; 2005 Mar; 65(3):364-74. PubMed ID: 15787967
[TBL] [Abstract][Full Text] [Related]
3. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage.
Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y
J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064
[TBL] [Abstract][Full Text] [Related]
4. Water soluble cyclosporine monomethoxy poly(ethyleneglycol) conjugates as potential prodrugs.
Cho H; Chung Y
Arch Pharm Res; 2004 Jun; 27(6):662-9. PubMed ID: 15283470
[TBL] [Abstract][Full Text] [Related]
5. A water-soluble prodrug of cyclosporine A for ocular application: a stability study.
Lallemand F; Perottet P; Felt-Baeyens O; Kloeti W; Philippoz F; Marfurt J; Besseghir K; Gurny R
Eur J Pharm Sci; 2005 Sep; 26(1):124-9. PubMed ID: 15978789
[TBL] [Abstract][Full Text] [Related]
6. Controlled drug release: new water-soluble prodrugs of an HIV protease inhibitor.
Matsumoto H; Sohma Y; Kimura T; Hayashi Y; Kiso Y
Bioorg Med Chem Lett; 2001 Feb; 11(4):605-9. PubMed ID: 11229781
[TBL] [Abstract][Full Text] [Related]
7. Biological conversion of a water-soluble prodrug of cyclosporine A.
Lallemand F; Varesio E; Felt-Baeyens O; Bossy L; Hopfgartner G; Gurny R
Eur J Pharm Biopharm; 2007 Sep; 67(2):555-61. PubMed ID: 17475453
[TBL] [Abstract][Full Text] [Related]
8. Conversion of cyclosporine A prodrugs in human tears vs rabbits tears.
Lallemand F; Felt-Baeyens O; Rudaz S; Hamel AR; Hubler F; Wenger R; Mutter M; Besseghir K; Gurny R
Eur J Pharm Biopharm; 2005 Jan; 59(1):51-6. PubMed ID: 15567301
[TBL] [Abstract][Full Text] [Related]
9. O-N intramolecular acyl migration reaction in the development of prodrugs and the synthesis of difficult sequence-containing bioactive peptides.
Sohma Y; Hayashi Y; Skwarczynski M; Hamada Y; Sasaki M; Kimura T; Kiso Y
Biopolymers; 2004; 76(4):344-56. PubMed ID: 15386265
[TBL] [Abstract][Full Text] [Related]
10. Dipeptide derivatives of AZT: synthesis, chemical stability, activation in human plasma, hPEPT1 affinity, and antiviral activity.
Santos C; Morais J; Gouveia L; de Clercq E; Pannecouque C; Nielsen CU; Steffansen B; Moreira R; Gomes P
ChemMedChem; 2008 Jun; 3(6):970-8. PubMed ID: 18389514
[TBL] [Abstract][Full Text] [Related]
11. In vivo characterisation of a novel water-soluble Cyclosporine A prodrug for the treatment of dry eye disease.
Rodriguez-Aller M; Kaufmann B; Guillarme D; Stella C; Furrer P; Rudaz S; El Zaoui I; Valamanesh F; Di Tommaso C; Behar-Cohen F; Veuthey JL; Gurny R
Eur J Pharm Biopharm; 2012 Apr; 80(3):544-52. PubMed ID: 22155591
[TBL] [Abstract][Full Text] [Related]
12. No auxiliary, no byproduct strategy for water-soluble prodrugs of taxoids: scope and limitation of O-N intramolecular acyl and acyloxy migration reactions.
Skwarczynski M; Sohma Y; Noguchi M; Kimura M; Hayashi Y; Hamada Y; Kimura T; Kiso Y
J Med Chem; 2005 Apr; 48(7):2655-66. PubMed ID: 15801856
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, chemical and enzymatic hydrolysis, and bioavailability evaluation in rabbits of metronidazole amino acid ester prodrugs with enhanced water solubility.
Mahfouz NM; Hassan MA
J Pharm Pharmacol; 2001 Jun; 53(6):841-8. PubMed ID: 11428660
[TBL] [Abstract][Full Text] [Related]
14. Strategies toward Organic Carbon Monoxide Prodrugs.
Ji X; Wang B
Acc Chem Res; 2018 Jun; 51(6):1377-1385. PubMed ID: 29762011
[TBL] [Abstract][Full Text] [Related]
15. Cyclization-activated prodrugs. Synthesis, reactivity and toxicity of dipeptide esters of paracetamol.
Santos C; Mateus ML; dos Santos AP; Moreira R; de Oliveira E; Gomes P
Bioorg Med Chem Lett; 2005 Mar; 15(6):1595-8. PubMed ID: 15745804
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and characterization of ester-based prodrugs of glucagon-like peptide 1.
De A; DiMarchi RD
Biopolymers; 2010; 94(4):448-56. PubMed ID: 20593470
[TBL] [Abstract][Full Text] [Related]
17. Conformation of MeAla6-cyclosporin A by NMR. Relationship of sidechain orientation of the MeBmt-1, MeLeu-9, and MeLeu-10 residues to immunosuppressive activity.
Gooley PR; Durette PL; Boger J; Armitage IM
Int J Pept Protein Res; 1991 May; 37(5):351-63. PubMed ID: 1917291
[TBL] [Abstract][Full Text] [Related]
18. Water-soluble prodrugs of dipeptide HIV protease inhibitors based on O-->N intramolecular acyl migration: Design, synthesis and kinetic study.
Hamada Y; Matsumoto H; Yamaguchi S; Kimura T; Hayashi Y; Kiso Y
Bioorg Med Chem; 2004 Jan; 12(1):159-70. PubMed ID: 14697781
[TBL] [Abstract][Full Text] [Related]
19. Syntheses of cyclic prodrugs of RGD peptidomimetics with various macrocyclic ring sizes: evaluation of physicochemical, transport and antithrombic properties.
He HT; Xu CR; Song X; Siahaan TJ
J Pept Res; 2003 Jun; 61(6):331-42. PubMed ID: 12753380
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, biological activity, and conformational analysis of (2S,3R,4S)-MeBmt1-cyclosporin, a novel 1-position epimer of cyclosporin A.
Rich DH; Sun CQ; Guillaume D; Dunlap B; Evans DA; Weber AE
J Med Chem; 1989 Aug; 32(8):1982-7. PubMed ID: 2754718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
